This document provides information about the 9th Annual Conference and Exhibition on Social Media in the Pharmaceutical Industry, which will take place on January 18-19, 2017 in London. The conference will feature keynote speakers from major pharmaceutical companies discussing topics such as using social media for customer engagement, clinical trial recruitment, and managing crises. It will also include workshops on January 17th on how private messaging may challenge the pharmaceutical industry and on identifying and mapping online influencers. The document provides an agenda with session topics, speakers, and registration information for the two-day conference.
Who are the pharma social media butterflies?Ogilvy Health
Who is doing the most proactive social media engagement within the pharmaceutical industry? Should pharma really compare itself to other sectors when it comes to social media? Is pharma’s use of social media evolving in the right direction? What are the defining characteristics of those pharma companies who are engaging more?
These are just some of the questions we keep hearing when it comes to pharma and social media. So we thought a bit of analysis of the industry would be interesting to see who was driving the party and who was standing back to watch and learn – the social butterflies and wallflowers.
Collaborative Digital Pharma Marketing: A Role Model for Asia Pacific Healthc...Len Starnes
Presentation first given 10th March 2011 in Singapore at the Campaign Spotlight 'From Drugs to Brands' conference. Reviews the potential of collaborative marketIng in the Asia Pacific region with focus on physicians and patients.
MSLGROUP Reputation: with or without youMSL Germany
Für die Umfrage „Reputation: with or without you“ der MSLGROUP wurden leitende Kommunikationsmanager von 100 ausgewählten Unternehmen wie Siemens, BASF, ZF Friedrichshafen, Commerzbank oder RWE AG interviewt, um aktuelle Trends im Corporate Reputation Management zu identifizieren. Die Aussagen der Interviewten führen zu fünf praxisrelevanten Erfolgsprinzipien für die Entwicklung einer zukunftsfähigen Unternehmenskommunikation, die wir in der Publikation näher erläutern.
Growing global competition,saturated markets and media
fragmentation are putting more pressure on marketersto
justify how they spend their marketing budgets. Digital has
proved to be a unique and flexible medium that can deliver
across all areas of marketing communication and within the
entire purchase funnel.
We’ve come a long way since the first online advertising
banner wassold and displayed. What began with the humble
fullsize banner has evolved into hundreds of online ad formats.
New media advertising offers multiple opportunities and
benefitsthat traditional media do not; it isthe ability to target
audiences precisely and accountability through measurement
that we are most concerned with in this white paper.
Who are the pharma social media butterflies?Ogilvy Health
Who is doing the most proactive social media engagement within the pharmaceutical industry? Should pharma really compare itself to other sectors when it comes to social media? Is pharma’s use of social media evolving in the right direction? What are the defining characteristics of those pharma companies who are engaging more?
These are just some of the questions we keep hearing when it comes to pharma and social media. So we thought a bit of analysis of the industry would be interesting to see who was driving the party and who was standing back to watch and learn – the social butterflies and wallflowers.
Collaborative Digital Pharma Marketing: A Role Model for Asia Pacific Healthc...Len Starnes
Presentation first given 10th March 2011 in Singapore at the Campaign Spotlight 'From Drugs to Brands' conference. Reviews the potential of collaborative marketIng in the Asia Pacific region with focus on physicians and patients.
MSLGROUP Reputation: with or without youMSL Germany
Für die Umfrage „Reputation: with or without you“ der MSLGROUP wurden leitende Kommunikationsmanager von 100 ausgewählten Unternehmen wie Siemens, BASF, ZF Friedrichshafen, Commerzbank oder RWE AG interviewt, um aktuelle Trends im Corporate Reputation Management zu identifizieren. Die Aussagen der Interviewten führen zu fünf praxisrelevanten Erfolgsprinzipien für die Entwicklung einer zukunftsfähigen Unternehmenskommunikation, die wir in der Publikation näher erläutern.
Growing global competition,saturated markets and media
fragmentation are putting more pressure on marketersto
justify how they spend their marketing budgets. Digital has
proved to be a unique and flexible medium that can deliver
across all areas of marketing communication and within the
entire purchase funnel.
We’ve come a long way since the first online advertising
banner wassold and displayed. What began with the humble
fullsize banner has evolved into hundreds of online ad formats.
New media advertising offers multiple opportunities and
benefitsthat traditional media do not; it isthe ability to target
audiences precisely and accountability through measurement
that we are most concerned with in this white paper.
Explains the evolution of Social Media, Conceptual viewpoint of digital Activities and healthcare Gamification. For more information visit: http://www.transformhealth-it.org/
Mobile Trends in Pharma & Healthcare Advertising | Silverlight Digital lorigo
Seventy percent of Internet use is now on mobile — and taking market share from other platforms. Adapted from a live presentation from Google NY’s Mobile Trends in Pharma & Healthcare Advertising Event, Silverlight Digital explores key trends that pharma and healthcare advertisers must take advantage of to increase performance in today's marketplace.
Re:Imagine Pharma Marketing - Agenda at a Glancebarberenar
There have been many COVID driven impacts on customer engagement and marketing processes, tools, and tactics. However, even with the advancement of digital marketing and commercial transformation, in-person engagement still remains the cornerstone of the pharma marketing business.
While we should celebrate the small wins and pivots that have been made as a result of COVID forced change, it is vital to understand which of these changes are transitory and which are true, long lasting transformations and innovation to be built on, and embedded in future processes and planning.
What will be our indicators and measurements of value moving forward?
What are the content consumption habits/behaviors of HCPs now?
How can I de-risk from supply chain to product development to commercial activity?
How can I diversify our clinical trial recruitment and innovation?
Does reimbursement need to be integrated with innovation?
How can I effectively virtualize customer engagement, branding and product launches?
What is the right promotional mix, even if/when sales force can return?
To what extent are the different stakeholder activities changing/overlapping as business needs evolve?
These are just a fraction of the issues currently creating bottlenecks that require proactive future planning and careful roadmap development.
Join our expert speaker faculty, the Thought Leadership Council and many of your industry peers to develop this roadmap together as a true community.
Case studies in developing, implementing, introducing and managing a brand from:
Government of NSW
Australian National University
Arrow Internet
National Disability Insurance Scheme
The Salvation Army
Evolve Housing
CareerOne
Creation Healthcare and Creation Pinpoint - An introductionCREATION
Creation Pinpoint is a unique service developed to provide insight into the conversations and concerns of healthcare professionals around the world. In this presentation, learn about the history of Creation Healthcare, the company behind Creation Pinpoint, and find out how this service may benefit your healthcare communication needs.
2011 WAFIC Using Social Media In Your Marketing PlanJustin Tamsett
So you have a Facebook page, a You Tube channel, a Flickr account and sending the odd Tweet but what is the return on investment for the business?
This session will share how to integrate what you are doing on-line with your marketing plan.
You will walk away with the tools you need to monitor your website and manage your social media.
And more importantly, you will learn how to maximise your marketing plan by taking it on-line!
Explains the evolution of Social Media, Conceptual viewpoint of digital Activities and healthcare Gamification. For more information visit: http://www.transformhealth-it.org/
Mobile Trends in Pharma & Healthcare Advertising | Silverlight Digital lorigo
Seventy percent of Internet use is now on mobile — and taking market share from other platforms. Adapted from a live presentation from Google NY’s Mobile Trends in Pharma & Healthcare Advertising Event, Silverlight Digital explores key trends that pharma and healthcare advertisers must take advantage of to increase performance in today's marketplace.
Re:Imagine Pharma Marketing - Agenda at a Glancebarberenar
There have been many COVID driven impacts on customer engagement and marketing processes, tools, and tactics. However, even with the advancement of digital marketing and commercial transformation, in-person engagement still remains the cornerstone of the pharma marketing business.
While we should celebrate the small wins and pivots that have been made as a result of COVID forced change, it is vital to understand which of these changes are transitory and which are true, long lasting transformations and innovation to be built on, and embedded in future processes and planning.
What will be our indicators and measurements of value moving forward?
What are the content consumption habits/behaviors of HCPs now?
How can I de-risk from supply chain to product development to commercial activity?
How can I diversify our clinical trial recruitment and innovation?
Does reimbursement need to be integrated with innovation?
How can I effectively virtualize customer engagement, branding and product launches?
What is the right promotional mix, even if/when sales force can return?
To what extent are the different stakeholder activities changing/overlapping as business needs evolve?
These are just a fraction of the issues currently creating bottlenecks that require proactive future planning and careful roadmap development.
Join our expert speaker faculty, the Thought Leadership Council and many of your industry peers to develop this roadmap together as a true community.
Case studies in developing, implementing, introducing and managing a brand from:
Government of NSW
Australian National University
Arrow Internet
National Disability Insurance Scheme
The Salvation Army
Evolve Housing
CareerOne
Creation Healthcare and Creation Pinpoint - An introductionCREATION
Creation Pinpoint is a unique service developed to provide insight into the conversations and concerns of healthcare professionals around the world. In this presentation, learn about the history of Creation Healthcare, the company behind Creation Pinpoint, and find out how this service may benefit your healthcare communication needs.
2011 WAFIC Using Social Media In Your Marketing PlanJustin Tamsett
So you have a Facebook page, a You Tube channel, a Flickr account and sending the odd Tweet but what is the return on investment for the business?
This session will share how to integrate what you are doing on-line with your marketing plan.
You will walk away with the tools you need to monitor your website and manage your social media.
And more importantly, you will learn how to maximise your marketing plan by taking it on-line!
Riding the next wave of PR and social media trends in 2019Lars Voedisch
Where and how to engage your audiences: From IGTV, TicToc and stories to Dark Social
How to connect with today’s audiences: Brand experiences and values
Why it’s all about touchpoints and personas
Speed update: 2019 social media and PR trends brands can’t afford to miss
Acute scrotum is a general term referring to an emergency condition affecting the contents or the wall of the scrotum.
There are a number of conditions that present acutely, predominantly with pain and/or swelling
A careful and detailed history and examination, and in some cases, investigations allow differentiation between these diagnoses. A prompt diagnosis is essential as the patient may require urgent surgical intervention
Testicular torsion refers to twisting of the spermatic cord, causing ischaemia of the testicle.
Testicular torsion results from inadequate fixation of the testis to the tunica vaginalis producing ischemia from reduced arterial inflow and venous outflow obstruction.
The prevalence of testicular torsion in adult patients hospitalized with acute scrotal pain is approximately 25 to 50 percent
These lecture slides, by Dr Sidra Arshad, offer a quick overview of physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar leads (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...VarunMahajani
Disruption of blood supply to lung alveoli due to blockage of one or more pulmonary blood vessels is called as Pulmonary thromboembolism. In this presentation we will discuss its causes, types and its management in depth.
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
Knee anatomy and clinical tests 2024.pdfvimalpl1234
This includes all relevant anatomy and clinical tests compiled from standard textbooks, Campbell,netter etc..It is comprehensive and best suited for orthopaedicians and orthopaedic residents.
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
NVBDCP.pptx Nation vector borne disease control program
Social Media in the Pharmaceutical Industry
1. www.social-media-pharma.com | #pharmasocialmedia
Register online or fax your registration to +44 (0) 870 9090 712 or call +44 (0) 870 9090 711
A: How will the rise of private messaging challenge
the pharma industry?
Workshop Leader:
Stine Moorgard Sorensen, Global Independent Digital Strategist, Former Digital
Interaction Business Partner, Stinesorenson, Lundbeck
8.30am - 12.30pm
B: Online influencer (key opinion leader/key opinion
influencer) identification and mapping
Workshop Leader:
Jackie Cuyvers, Co- Founder, the Conversationalist Agency
13.30pm - 17.00pm
PLUS TWO INTERACTIVE HALF-DAY PRE-CONFERENCE WORKSHOPS | TUESDAY 17TH JANUARY 2017, HOLIDAY INN KENSINGTON FORUM, LONDON, UK
@SMIPHARM
CHAIRMAN FOR 2017:
Daniel Ghinn, Founder & CEO,
Creation Healthcare
KEYNOTE SPEAKERS INCLUDE:
Julie O’Donnell, Senior Director; Head of
Global Customer Interaction Management,
Lundbeck
Phil Tregunno, Signal Management Unit
Manager, WEB-RADR Project Lead, MHRA
Thibaud Guymard, Head of Digital Services,
MSD
Doris Casares, Communications Director,
Medicines for Europe
Scott Gavin, Regional Lead, Digital Centre of
Excellence / Digital Services, Pfizer
Dimithri Wignarajah, Head of Content & Social
Media, GE Healthcare Life Sciences
REASONS TO ATTEND:
• Get insights from MHRA on new mobile
app, WEB-RADR, its development, use in
pharmacovigilance, policy and ethical
guidance on appropriate use
• Case studies on how to skilfully create engaging
content online from Pfizer
• Using social media in crisis management and
analytic predictions
• New insights and case study on how social
media is being used for employee advocacy in
healthcare and pharma
18TH - 19TH
JAN
2017HOLIDAY INN KENSINGTON FORUM, LONDON, UK
SMi Presents the 9th Annual Conference and Exhibition on
Social Media in the
Pharmaceutical Industry
Strengthening and influencing online discussions to
improve brand reputation
BOOK BY 30TH SEPTEMBER AND SAVE £400
BOOK BY 31ST OCTOBER AND SAVE £200
BOOK BY 30TH NOVEMBER AND SAVE £100
“Content was excellent and
presented different viewpoints.”
Delegate 2016
2. Social Media in the Pharmaceutical Industry
Day One | Wednesday 18th January 2017 www.social-media-pharma.com
08.30 Registration & Coffee
09.00 Chairman’s Opening Remarks
Daniel Ghinn, CEO& Founder, Creation Healthcare
SOCIAL LISTENING AND DIGITAL MARKETING
OPENING ADDRESS
09.10 Using social media to predict the future of healthcare
• Understanding how healthcare professionals (HCPs) use social
media to interact with peers and discuss therapy areas.
• Identifying how HCPs discuss products and how that
conversation can influence the market
• Use of social media and big data in crisis management
Daniel Ghinn, CEO& Founder, Creation Healthcare
09.50 From talking fish to talking parrots: the zany world of pharma
social media
• What’s with the talking animals and pharma social media
campaigns?
• A look at a selection of amazing campaigns
• Will the real competitor please stand up – how liquid
expectations shape our work
• What next - trends affecting the future of health
John Pugh, Life Science Innovation Lead, Accenture
10.30 Morning Coffee
10.50 Hard lessons: embedding social media into multi-channel
customer journey in the UK market
• Launching a campaign with limited scope: a learning
opportunity
• Social Media: Business needs versus regulatory compliance and
how to get approval
• Getting idea shot down even with approval- what experiences
can be gained and how should you proceed?
• A social media campaign that fails to deliver on its Key
performance indicators (KPIs) is not a failure. It is a low-cost
learning opportunity
• Results - presenting both sides of the coin and measuring the
efficacy of a campaign
Piotr Wrzosinski, Digital & Multichannel Marketing Manager,
Janssen Pharmaceuticals
11.30 Setting the benchmark for pharma social listening
• Learn the current benchmark for conversation on key
therapeutic areas globally and by region
• Understand who is leading the conversation, and how much
HCP’s contribute to the conversation
• Receive the most up-to-date facts and figures of key
stakeholder engagement online globally and regionally
• Come away with global and local benchmarks to measure your
social listening efforts, and social campaign success
Jackie Cuyvers, Co-Founder, Digital Strategist,
the Conversationalist Agency
12.10 Networking Lunch
13.30 Social networks for HCPs
• comuniti.fr- learn about how this platform is being used by
healthcare professionals
• What are HCPs talking about and how can this help pharma
engagement
• Where are these conversations taking place? Global/ Regional
– identifying the needs of HCPs in relation to their geography
Thibaud Guymard, Head of Digital Services, MSD
14.10 Establishing digital services within a leading pharma organisation
• The opportunity for dedicated social media digital services
within Pharma
• The challenges of setting up social media digital services within
Pharma
• Service design and delivery
• How we are delivering value, some case studies
Scott Gavin, Regional Lead, Digital Centre of Excellence, Pfizer
14.50 Afternoon Tea
15.10 Shaping the pharma landscape through a re-branding process
• How do we use Social Media platforms to better convey our
messages? The video experience
• Engaging with patients and advocacy partners across Europe
from a trade association
• Health Digital Trends 2017- maximise your company’s reach by
staying up to date with shifts in social media
Doris Casares, Communications Director, Medicines for Europe
CONTENT CREATION
15.50 Why your social media content should be less “promotional” and
more about storytelling
• What does good social media content look like today, and how
is it changing?
• Which content frameworks and tools can help you understand
your audience and create better content to engineering a
successful social media strategy?
• What can be gained from targeted content? The difference
between traditional digital marketing and valuable, relevant,
customer centric content?
Stine Mølgaard Sørensen, Global Independent Digital Strategist,
Former Global Digital Interaction Business Partner, Stinesorenson,
Lundbeck
16.30 Chairman’s Closing Remarks and Close of Day One
Register online at www.social-media-pharma.com
SPONSORSHIP AND EXHIBITION OPPORTUNITIES
SMi offer sponsorship, exhibition, advertising and branding packages, uniquely tailored to complement your company’s marketing strategy. Prime
networking opportunities exist to entertain, enhance and expand your client base within the context of an independent discussion specific to your
industry. Should you wish to join the increasing number of companies benefiting from sponsoring our conferences please call:
Alia Malick on +44 (0) 20 7827 6168 or email: amalick@smi-online.co.uk
SMi PHARMACEUTICAL FORWARD PLANNER
SEPTEMBER
Cancer Vaccines
21st - 22nd September 2016, London, UK
Biosimilars Europe
29th - 30th September 2016, London, UK
OCTOBER
European Market Access, Pricing
& Reimbursement in Pharma
10th - 11th October 2016, London, UK
Orphan Drugs
19th - 20th October 2016, London, UK
COPD: Novel Therapeutics
and Management Strategies
19th - 20th October 2016, London, UK
NOVEMBER
Superbugs & Superdrugs USA
14th - 15th November 2016
New Jersey, USA
Biosimilars USA
16th - 17th November 2016
New Jersey, USA
DECEMBER
Cold Chain Distribution
12th - 13th December 2016,
London, UK
JANUARY
Pharmaceutical Microbiology
18th - 19th January 2017
London, UK
Social Media In The Pharma Industry
18th - 19th January 2017, London, UK
Pre-Filled Syringes Europe
18th - 19th January 2017, London, UK
FEBRUARY
Parallel Trade
6th - 7th February 2017, London, UK
3D Cell Culture
22nd - 23rd February 2017, London, UK
RNAi Therapeutics
22nd - 23rd February 2017, London, UK
MARCH
Superbugs & Superdrugs - A Focus on
Antibacterials
15th - 16th March 2017, London, UK
Paediatric Clinical Trials
15th - 16th March 2017, London, UK
Drug Discovery
27th - 28th March 2017
London, UK
Asthma & COPD
29th - 30th March 2017
London, UK
3. Social Media in the Pharmaceutical Industry
www.social-media-pharma.com Day Two | Thursday 19th January 2017
08.30 Registration & Coffee
09.00 Chairman’s Opening Remarks
Daniel Ghinn, CEO & Founder, Creation Healthcare
ADVANCEMENTS IN TECHNOLOGY AND ITS EFFECT ON INDUSTRY
OPENING KEYNOTE ADDRESS
09.10 Unearthing new opportunities in social media for your brand or
target audience
• Taking the pulse of your audience – practical tips
• Understanding the big players and emerging opportunities
on social channels – from Twitter to Snapchat, from Figure1 to
WeChat
• How to future proof your strategy – Content strategy? Channel
strategy? Platform strategy? Distribution strategy? Can you see
the wood for the trees?
Julie O’Donnell, Senior Director Head of Global Customer
Interaction Management, Lundbeck
09.50 WEB-RADR: Mobile Technologies in Pharmacovigilance
• Overview of the EU Innovative Medicines Initiative’s WEB-RADR
project
• Mobile apps and social media data in pharmacovigilance
• Analysis strategies
• Policy and ethical guidance on appropriate use
Phil Tregunno, Signal Management Unit Manager, WEB-RADR
Project Lead, MHRA
10.30 Morning Coffee
10.50 Attracting our customers through social media: building customer
engagement and corporate confidence through a test and evolve
approach
• Why social media? As technology evolves, consumer relations
change making it paramount that pharma does not get left
behind. Explore the many ways social platforms can work for you
• Engaging internal stakeholders
• Starting small to raise confidence and competence - how Pfizer
is using Youtube and Twitter to optimise engagement
• Evolving and expanding- how to make sure your social media
strategy up to date and advancing
Sarah Sunderland, Regional Digital Marketing Manager, Europe,
Japan, Australia, New Zealand, Pfizer
11.30 Social media as a resource for clinical trial engagement and
recruitment
• Benefits of using digital and traditional cross platform strategies
to engage with patients
• The power of language, design and content when targeting
patient populations
• Reaching out to global subjects to increase enrolment
• Case studies
• Success – data on efficacy
Penny Goddard, Senior Manager Patient Recruitment and
Retention, AbbVie Ltd
12.10 Networking Lunch
13.30 Social networking: you, me & the company
• Employee activation: an innovative way to inspire employees
with your company’s purpose
• Learn how to enhance brand trust and engagement with social
strategy and marketing with different platforms
• LinkedIn & employee advocacy
• The customer journey- how are customers interacting with social
platforms in pharma and does this lead to increased interest in a
company?
Dimithri Wignarajah, Head of Content and Social Media,
GE Healthcare
REGULATORY LANDSCAPES
14.10 The regulation & assessment of medical apps
• Gain critical information on how mHealth apps can deliver
benefit and maximise engagement
• Why good regulation is so important?
• Find out about the expected future regulatory changes and
eliminate the risks involved in the creation and marketing of
medical health apps
• An effective overview of the EU voluntary privacy code of
conduct- get up to date and avoid violations of privacy.
• How mHealth app assessment is being handled in both the UK &
EU: when will we see the results?
Charles Lowe, Managing Director, Digital Health and Care
Alliance
14.50 Afternoon Tea
EDUCATING, ENGAGING AND EMPOWERING
15.10 Engaging and empowering consumers through social platforms
• Making a campaign vs. making a long term engagement
commitment
• How to combine social media outreach with your own digital
platform
• Concrete examples from LEO Pharma’s Digital Patient
Engagement activities for people living with psoriasis
• How to give people with psoriasis the confidence to take control
with digital tools and services
Jakob Hansen, Digital Patient Engagement Manager, Leo Pharma
15.50 What do doctors talk about online?
• Where do they go when they are discussing things (open vs
closed networks?)
• What are the regulations that govern their online behaviour?
• What are the implications of social media for the pharma
industry?
• How could pharma safely engage in this space?
James Quekett, Director for Primary Care, M3 (EU), Doctors.net.uk
16.30 Chairman’s Closing Remarks and Close of Day Two
Alternatively fax your registration to +44 (0)870 9090 712 or call +44 (0)870 9090 711
SUPPORTED BY
Want to know how you can get involved? Interested in promoting your services to this market?
Contact Honey De Gracia, SMi Marketing on
+44 (0)20 7827 6102 or email: hdegracia@smi-online.co.uk
OFFICIAL MEDIA PARTNERS OFFICIAL PUBLICATIONS
4. HALF DAY PRE-CONFERENCE WORKSHOP A
Tuesday 17th January 2017
Holiday Inn Kensington Forum, London, UK
8.30am - 12.30pm
How will the rise of private
messaging challenge the
pharma industry?
Workshop Leader:
Stine Moorgard Sorensen, Global Independent Digital
Strategist, Former Digital Interaction Business Partner,
Stinesorenson, Lundbeck
Workshop overview:
One of the most interesting digital trends to look out for in 2017
is private messaging. In fact there’s in general a shift towards
more private and one-on-one communication. Platforms like
WhatsApp, Facebook Messenger and WeChat are platforms
that have seen significant growth in 2016. Facebook is investing
heavily in this area too, and in the first quarter of 2016 Business
Insider reported that the time spent on messaging platforms
surpassed the time spent on social media platforms. This will
heavilychallengethewayinwhichseveralbrandscommunicate
online today, and it raises the question: How can we remain
relevant when the audience basically just want to go online to
have conversations with their family and friends?
Key benefits of attending:
• Discover the latest trends and tendencies within digital based
on insights from the world’s leading tech conferences.
• Get insights into the ways consumers are actually using social
media today and we will discuss: “Is social media really that
social in the future”?
• Explore the novel strategies being employed by companies
maximising their reach through private messaging
technology
• Learn how pharma can take the first steps towards
understanding how consumers are communicating and
identifying topics of engagement.
• Get new perspectives on your work with digital in the wealth
of opportunities that lies within
• Receive renewed inspiration and perspective on your digital
work that you can bring back to the office and share
Agenda
08.30 Registration and coffee
09.00 Opening remarks and introductions
09.00 Session 1: How is the digital landscape evolving,
change in behavior and where are we heading?
• Interactive group discussion on experiences with
social/ digital
• The general trends and tendencies in digital
platforms
• Insight into traditional methods of social media
strategy
• Evaluating some of the ways which pharma is
currently engaging with consumers- indirect, mass
media campaigns.
09.50 Session 2: The ‘social’ arena how social are
consumers really?
• We will explore the behaviour of consumers and the
platforms being used
• Reasons for behavioural shifts on digital platforms
and how to adapt to consumer needs.
10.30 Morning coffee
11.00 Session 3: Case study: Who are the key players in
this field?
• Presentation of case studies- Presentation of cases –
Which companies can be we learn form from at this
stage?
• Tips on how to strategically implement some of the
techniques already being harnessed by companies
successfully utilizing messaging platforms.
11.45 Session 4: Dealing with compliance
• Discussion on current guidelines- issues to think about
before acting
• Ways in which companies are staying within
regulations whilst benefiting from new technology
• Q&A session
12.20 Closing remarks
About the Workshop Leader:
StineSørensenistheco-founderofGeekGirlDenmark,
a growing network for women within the digital
space with over 1400 members. Stine most recently
worked for Lundbeck A/S, leading the development
of their corporate global digital strategy, and social
media presence, as well as supporting their major brands to
define their own digital and social media programmes. She
has more than 5 years of agency experience working as a
digital strategist for various clients within the tech industry around
Europe and holds a master’s degree in communication and
business administration from Roskilde University. Today she works
as a Global Independent Digital Strategist, trying to define how
technology will impact the way we do business and mentoring
tech startups in Denmark and Mauritius. She is also a jury member
at this year’s European Digital Communications Award.
5. HALF DAY PRE-CONFERENCE WORKSHOP B
Tuesday 17th January 2017
Holiday Inn Kensington Forum, London, UK
13.30pm - 17.00pm
Online influencer (key opinion
leader/ key opinion influencer)
identification and mapping
Workshop Leader:
Jackie Cuyvers, Co- Founder, the Conversationalist Agency
Workshop overview:
Pharma brands are actively looking for ways to access
and engage key HCPs and online influencers. However,
before they can become advocates – you first need
to find the right influencers, and know what topics to
engage them on, which channels or platforms, and if
they already advocate for your competitors.
Thisworkshopwillbeahands-onworkshopinunderstanding
the approach, methodology and framework for defining
your criteria of “influencers,” identifying online influencers
and mapping key correlations at a regional and global
level for activation and advocacy
Key benefits of attending:
• Understand and define your criteria for who is an
influencer
• Learn how to identify influencers and their sphere of
influence
• Regional vs Global -using themes and correlations to
develop personas
• Develop a methodology for prioritisation of influencers
to engage
• Have a keen understanding of the process to know
what good looks like
Agenda
13.30 Registration and coffee
14.00 Opening remarks and introductions
14.10 Session 1
• Understand and define your criteria for who is
an influencer
• The difference between KOLs and KOIs
• Defining the value of influencers
14.50 Session 2
• Regional vs Global - using themes and
correlations to develop personas
• Develop a methodology for prioritisation of
influencers to engage
• Going beyond the influencer to identify their
sphere of influence
15.30 Afternoon Tea
16.00 Session 3: Online influencer (key opinion
leader/ key opinion influencer) identification
and mapping
• Action steps for engagement and advocacy
• Case studies: What ‘good’ looks like
• Q&A
17.00 Closing remarks
About the Workshop Leader:
Jackie Cuyvers, is the CEO and Co-Founder
of The Conversationalist Agency, where she
leads a global team of over 150 multi-lingual
social listening analysts identify actionable
insights from online content, across the globe.
She’s run Social Listening projects from Azerbaijan to
Zimbabwe and all points in between. Jackie has an MBA
in International Marketing is based in London and has
over 15+ years of experience in Digital Marketing and
Social Media Strategy, Engagement and Analysis. The
last 8 years she has been focused on using Social Data
for developing Pharma & Healthcare business insights.
About the Organisation:
We provide expert
multilingual Social Media
Analysts to Agencies and
Enterprise for Patient &
HCP insight. We conduct Social Listening and Social
Media Analytics for global and regional Pharma projects
across all social listening tools, social platforms, channels
and geographies.We specialise in: social media, social
listening, social strategy, community management, social
media listening, multilingual social media monitoring,
Social Media Analytics, multilingual social analysts.
6. Please complete fully and clearly in capital letters. Please photocopy for additional delegates.
Title: Forename:
Surname:
Job Title:
Department/Division:
Company/Organisation:
Email:
Company VAT Number:
Address:
Town/City:
Post/Zip Code: Country:
Direct Tel: Direct Fax:
Mobile:
Switchboard:
Signature: Date:
I agree to be bound by SMi’s Terms and Conditions of Booking.
ACCOUNTS DEPT
Title: Forename:
Surname:
Email:
Address (if different from above):
Town/City:
Post/Zip Code: Country:
Direct Tel: Direct Fax:
SOCIAL MEDIA IN THE PHARMACEUTICAL INDUSTRY
Conference: 18th -19th January 2017, Holiday Inn Kensington Forum, London, UK Workshops: 17th January 2017, London
4 WAYS TO REGISTER
FAX your booking form to +44 (0) 870 9090 712
PHONE on +44 (0) 870 9090 711
ONLINE at www.social-media-pharma.com
POST your booking form to: Events Team, SMi Group Ltd,
1 Westminster Bridge Road, London, SE1 7XW
If you have any further queries please call the Events Team on tel +44 (0) 870 9090 711 or you can email them at events@smi-online.co.uk
Payment: If payment is not made at the time of booking, then an invoice will be issued and must
be paid immediately and prior to the start of the event. If payment has not been received then
credit card details will be requested and payment taken before entry to the event. Bookings within
7 days of event require payment on booking. Access to the Document Portal will not be given until
payment has been received.
Substitutions/Name Changes: If you are unable to attend you may nominate, in writing, another
delegate to take your place at any time prior to the start of the event. Two or more delegates may
not ‘share’ a place at an event. Please make separate bookings for each delegate.
Cancellation: If you wish to cancel your attendance at an event and you are unable to send
a substitute, then we will refund/credit 50% of the due fee less a £50 administration charge,
providing that cancellation is made in writing and received at least 28 days prior to the start of the
event. Regretfully cancellation after this time cannot be accepted. We will however provide the
conferences documentation via the Document Portal to any delegate who has paid but is unable
to attend for any reason. Due to the interactive nature of the Briefings we are not normally able to
provide documentation in these circumstances. We cannot accept cancellations of orders placed
for Documentation or the Document Portal as these are reproduced specifically to order. If we
have to cancel the event for any reason, then we will make a full refund immediately, but disclaim
any further liability.
Alterations: It may become necessary for us to make alterations to the content, speakers, timing,
venue or date of the event compared to the advertised programme.
Data Protection: The SMi Group gathers personal data in accordance with the UK Data Protection
Act 1998 and we may use this to contact you by telephone, fax, post or email to tell you about
other products and services. Unless you tick here □ we may also share your data with third parties
offering complementary products or services. If you have any queries or want to update any of the
data that we hold then please contact our Database Manager databasemanager@smi-online.
co.uk or visit our website www.smi-online.co.uk/updates quoting the URN as detailed above your
address on the attached letter.
Unique Reference Number
Our Reference P-192
Terms and Conditions of Booking
DELEGATE DETAILS
Payment must be made to SMi Group Ltd, and received before the event,
by one of the following methods quoting reference P-192 and the delegate’s
name. Bookings made within 7 days of the event require payment on booking,
methods of payment are below. Please indicate method of payment:
□ UK BACS Sort Code 300009, Account 00936418
□ Wire Transfer Lloyds TSB Bank plc, 39 Threadneedle Street, London, EC2R 8AU
Swift (BIC): LOYDGB21013, Account 00936418
IBAN GB48 LOYD 3000 0900 9364 18
□ Cheque We can only accept Sterling cheques drawn on a UK bank.
□ Credit Card □ Visa □ MasterCard □ American Express
All credit card payments will be subject to standard credit card charges.
Card No: □□□□ □□□□ □□□□ □□□□
Valid From □□/□□ Expiry Date □□/□□
CVV Number □□□□ 3 digit security on reverse of card, 4 digits for AMEX card
Cardholder’s Name:
Signature: Date:
I agree to be bound by SMi’s Terms and Conditions of Booking.
Card Billing Address (If different from above):
DOCUMENTATION
I cannot attend but would like to Purchase access to the following Document Portal/
Paper Copy documentation. Price Total
□ Access to the conference documentation
on the Document Portal £499.00 + VAT £598.80
□ The Conference Presentations – paper copy £499.00 - £499.00
(or only £300 if ordered with the Document Portal)
PAYMENT
VAT
VAT at 20% is charged on the attendance fees for all delegates. VAT is also charged
on Document portal and literature distribution for all UK customers and for those EU
Customers not supplying a registration number for their own country here
CONFERENCE PRICES GROUP DISCOUNTS AVAILABLE
I would like to attend: (Please tick as appropriate) Fee TOTAL
□ Conference 2 Workshops £2697.00 + VAT £3236.40
□ Conference 1 Workshop □ A □ B £2098.00 + VAT £2517.60
□ Conference only £1499.00 + VAT £1798.80
□ 2 Workshops only £1198.00 + VAT £1437.60
□ 1 Workshop only □ A □ B £599.00 + VAT £718.80
PROMOTIONAL LITERATURE DISTRIBUTION
□ Distribution of your company’s promotional
literature to all conference attendees £999.00 + VAT £1198.80
The conference fee includes refreshments, lunch, conference papers, and access to
the Document Portal. Presentations that are available for download will be subject
to distribution rights by speakers. Please note that some presentations may not be
available for download. Access information for the document portal will be sent to
the e-mail address provided during registration. Details are sent within 24 hours post
conference.
VENUE Holiday Inn Kensington Forum, 97 Cromwell Road, London SW7 4DN
□ Please contact me to book my hotel
Alternatively call us on +44 (0) 870 9090 711,
email: events@smi-online.co.uk or fax +44 (0) 870 9090 712
□ Book by 30th September to receive £400 off the conference price
□ Book by by 31st October to receive £200 off the conference price
□ Book by 30th November to receive £100 off the conference price
EARLY BIRD
DISCOUNT